Cutaneous or Sub-cutaneous Malignancies
1 clinical trials · Condition
◉ Watch Cutaneous or Sub-cutaneous Malignancies
| Record | Firm | Date |
|---|---|---|
| Dose Escalating Study for Amphinex-based PCI of Bleomycin. (NCT01872923) | PCI Biotech AS | 2012-01-01 |
Track Cutaneous or Sub-cutaneous Malignancies automatically
Every clearance here is in the API, with alerts when new ones post.